Dr. Michael Seidman is Participating in a New Study to Test Treatment for Blast-induced Tinnitus.

Published date: |
Estimated read time: |
Authored by:
  • AdventHealth Research Institute
Topics:
Care Community

Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt sleep and concentration, negatively impacting daily quality of life and mental health. There is currently no cure.

That is why the AdventHealth Research Institute is excited to be participating in a new multi-site clinical trial funded by the U.S. Department of Defense. Under the leadership of Principal Investigator Michael Seidman, MD, this study will evaluate the efficacy of etanercept, a TNF-alpha blocker, as a potential treatment for blast-induced tinnitus. Click the button below to learn more.

Learn More

Recent News

News
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease

Under the leadership of Principal Investigator Valeria Baldivieso, MD, and Sub-Investigator Chandan Reddy, MD, MS, FAANS, the AdventHealth Research Institute is recruiting patients for the Exablate...

Read Article
View More Articles